Page last updated: 2024-10-30

loratadine and Daytime Sleepiness

loratadine has been researched along with Daytime Sleepiness in 3 studies

Loratadine: A second-generation histamine H1 receptor antagonist used in the treatment of allergic rhinitis and urticaria. Unlike most classical antihistamines (HISTAMINE H1 ANTAGONISTS) it lacks central nervous system depressing effects such as drowsiness.
loratadine : A benzocycloheptapyridine that is 6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine substituted by a chloro group at position 8 and a 1-(ethoxycarbonyl)piperidin-4-ylidene group at position 11. It is a H1-receptor antagonist commonly employed in the treatment of allergic disorders.

Research Excerpts

ExcerptRelevanceReference
"Loratadine was significantly superior to placebo in 3 of 10 trials (30%), consistent with rates found in 3 pivotal group trials used for FDA approval (24%, 17%, and 0%)."2.70Single-patient drug trial methodology for allergic rhinitis. ( Del Rio, E; Rebell, G; Reitberg, DP; Weiss, SL; Zaias, N, 2002)
" Somnolence scores were similar for both groups at baseline and at the time of dosing (8:00 AM)."2.69Loratadine versus cetirizine: assessment of somnolence and motivation during the workday. ( Gates, D; Greiding, L; Heithoff, K; Ramon, F; Salmun, LM; Scharf, M, 2000)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Reitberg, DP1
Del Rio, E1
Weiss, SL1
Rebell, G1
Zaias, N1
Salmun, LM1
Gates, D1
Scharf, M1
Greiding, L1
Ramon, F1
Heithoff, K1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Prescription Methods Assessment Project (PMAP)[NCT00393653]800 participants (Anticipated)Interventional2006-10-31Terminated (stopped due to Funding ended early)
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trials

2 trials available for loratadine and Daytime Sleepiness

ArticleYear
Single-patient drug trial methodology for allergic rhinitis.
    The Annals of pharmacotherapy, 2002, Volume: 36, Issue:9

    Topics: Adolescent; Adult; Aged; Anti-Allergic Agents; Child; Chlorpheniramine; Clinical Trials as Topic; Da

2002
Loratadine versus cetirizine: assessment of somnolence and motivation during the workday.
    Clinical therapeutics, 2000, Volume: 22, Issue:5

    Topics: Adult; Anti-Allergic Agents; Cetirizine; Disorders of Excessive Somnolence; Double-Blind Method; Eff

2000

Other Studies

1 other study available for loratadine and Daytime Sleepiness

ArticleYear
Desloratadine (Clarinex).
    The Medical letter on drugs and therapeutics, 2002, Mar-18, Volume: 44, Issue:1126

    Topics: Administration, Oral; Adolescent; Adult; Aged; Asthma; Controlled Clinical Trials as Topic; Disorder

2002